https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-24 / Front Oncol 2020;10:376
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-24 / Front Oncol 2020;10:3762020-03-24 00:00:002020-12-07 11:23:38Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients
https://www.iozk.de/wp-content/uploads/2020/03/UkvArtikel.jpg
1333
2008
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2020-03-20 09:18:482020-03-20 14:26:10Interview mit Dr. Wilfried Stücker: Umdenken in der Medizin – Neuere Formen der Krebstherapie
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-20 / Life Sci. 2020 Aug;254:117580
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-20 / Life Sci. 2020 Aug;254:1175802020-03-20 00:00:002020-03-20 00:00:00Dendritic cell therapy in cancer treatment; the state-of-the-art
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-19 / Cell. Mol. Immunol. 2020 04;17(4):323-334
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-19 / Cell. Mol. Immunol. 2020 04;17(4):323-3342020-03-19 00:00:002020-03-19 00:00:00The function and clinical application of extracellular vesicles in innate immune regulation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-17 / J Adv Res 2020 Jul;24:175-182
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-17 / J Adv Res 2020 Jul;24:175-1822020-03-17 00:00:002023-01-31 16:04:06A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2020-03-16 17:41:482020-05-20 11:33:51Prof. Dr. Volker Schirrmacher veröffentlicht zwei wegweisende Übersichtsartikel zur Immuntherapie
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-16 / Biomedicines 2020 Mar;8(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-16 / Biomedicines 2020 Mar;8(3)2020-03-16 00:00:002021-11-15 19:52:47Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e92020-03-16 00:00:002020-08-26 12:23:32Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-12 / Front Oncol 2020;10:343
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-12 / Front Oncol 2020;10:3432020-03-12 00:00:002020-03-12 00:00:00Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-03-12 / Pharmaceutics 2020 Mar;12(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-03-12 / Pharmaceutics 2020 Mar;12(3)2020-03-12 00:00:002020-08-26 13:44:51Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
